Scoopfeeds — Intelligent news, curated.
Benchmark reiterates Halozyme stock Buy rating on long-term potential
business

Benchmark reiterates Halozyme stock Buy rating on long-term potential

Investing.com · Jun 3, 2026, 1:49 PM · Also reported by 2 other sources

Benchmark reiterates Halozyme stock Buy rating on long-term potential

Read full story on Investing.com → More top stories

Also covered by

Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop